Atlas Trials

A Study to Evaluate the Pharmacokinetics of Entinostat in Adult Subjects With Normal and Impaired Renal Function

Clinical trial NCT03192111 · COMPLETED

Trial details

NCT number
NCT03192111
Sponsor
Syndax Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal ImpairmentHealthy Volunteer
Start date
2017-07-27
Primary completion
2017-11-23
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.